SCHEMBL9470943

SCHEMBL9470943

O=C(c1ccccc1)n1c(=O)c(F)cn([C@@H]2CC(O)[C@H](CO)O2)c1=O

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALOX12 P18054 1/20 0.45
ADRA1A P35348 1/20 0.45
KMT2A Q03164 1/20 0.45
TK1 P04183 3/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ADRB1 P08588 1/20 0.40
DNMT1 P26358 1/20 0.40
TK2 O00142 1/20 0.40
RNASE1 P07998 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9470932 1.00 LMNA (0.53) LMNASMN1; SMN2ALOX12ADRA1AKMT2A
SCHEMBL9470627 0.89 LMNA (0.55) LMNASMN1; SMN2ALOX12ADRA1AKMT2A
SCHEMBL9470617 0.89 LMNA (0.55) LMNASMN1; SMN2ALOX12ADRA1AKMT2A
SCHEMBL11144505 0.88 LMNA (0.48) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL11144500 0.88 LMNA (0.48) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL9443821 0.88 RNASE1 (0.48) LMNASMN1; SMN2TK1CYP1A2CYP3A4
SCHEMBL21563855 0.88 RNASE1 (0.48) LMNASMN1; SMN2TK1CYP1A2CYP3A4
SCHEMBL4728022 0.88 TK1 (0.53) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL537189 0.88 RNASE1 (0.48) LMNASMN1; SMN2TK1CYP1A2CYP3A4
SCHEMBL2922542 0.87 TK1 (0.42) LMNASMN1; SMN2ALOX12ADRA1ATK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60061591-A None JP disclosed
US-5250673-A Antitumor agents TAIHO PHARMACEUTICAL COMPANY, LTD. (JP) 1993-10-05 US disclosed
EP-0331032-B1 2'-DEOXY-5-FLUOROURIDINE DERIVATIVES TAIHO PHARMACEUTICAL CO., LTD. (JP) 1993-04-28 EP disclosed
US-5032680-A Antitumor KURARAY CO., LTD. (JP) 1991-07-16 US disclosed
US-4886877-A Novel 2'-deoxy-5-substituted uridine derivatives, processes for preparing the same and antitumor agent containing the same TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 1989-12-12 US disclosed
EP-0331032-A1 2'-Deoxy-5-fluorouridine derivatives TAIHO PHARMACEUTICAL CO., LTD. (JP) 1989-09-06 EP disclosed
EP-0129984-B1 NOVEL 2'-DEOXY-5-SUBSTITUTED URIDINE DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND ANTITUMOR AGENT CONTAINING THE SAME TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 1988-03-02 EP disclosed
JP-S6061591-A 2'-DEOXY-5-FLUOROURIDINE DERIVATIVE, ITS PREPARATION AND ANTITUMOR AGENT CONTAINING THE SAME TAIHO YAKUHIN KOGYO KK 1985-04-09 JP disclosed
EP-0129984-A1 Novel 2'-deoxy-5-substituted uridine derivatives, processes for preparing the same and antitumor agent containing the same TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 1985-01-02 EP disclosed